EN DE
Watch Nanollose Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Nanollose Limited (NC6) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of Nanollose Limited stock A$0.05, price A$0.07, that is 31.1% below the price, quality 32 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Cyclical AU · ISIN AU000000NC68

NL Nanollose Limited logo Thin data Nov 10, 2026

Nanollose Limited

NC6 · AU
Expensive, weak quality

Our calculation puts a fair price 31% below what the stock costs today.

Low debt
Revenue last quarter +32% vs. a year ago.
Fair value A$0.0469 · Overvalued
Quality 32/100
Weak Growth (revenue 5y −51.9 %/yr in AUD)
Negative free cash flow
Trails peers (2/8)
Narrow moat 8/100 · thin data
Thin data
Estimate
Watch Nanollose Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

A$0.1400 A$0.0160 Fair Value A$0.0469 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range A$0.0160 – A$0.1400 · fair‑value band A$0.0406 – A$0.0532 · the A$0.0680 price screens above the A$0.0469 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Nanollose in your weekly email

Every Wednesday you see whether Nanollose is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.

Show moreShow less

The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre for use in textiles; Jelli Grow, an alternative seed germination and plant growing material; and Nufolium that is used for nonwoven applications, such as wipes.

It also offers Biollose, a soilless growing media; and MicroGel, which is developed specifically for the commercial microgreens market. Nanollose Limited was incorporated in 2014 and is based in Nedlands, Australia.

Stock analysis

Nanollose Limited (NC6) currently trades at A$0.0680, while our estimate is A$0.0469, 31% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: A$0.0406 (bear) to A$0.0532 (bull), the price of A$0.0680 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 32/100 (below-average quality), in the Consumer Cyclical sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Nanollose Limited reported revenue of A$12.0K in FY2025 versus A$323K in FY2021, a compound −56.1%/yr. Reported net income was −A$2.4M in FY2026.

Key figures

Market cap A$27.3M (≈ $18.8M) Micro · P/S ratio 89.6 · EPS (TTM) A$−0.0100 · Return on equity −300% · Return on assets (EBIT) −243% (5-year average) · Operating margin −277% · Revenue growth (YoY) +31.7% · Free cash flow −A$1.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 18% below its 52-week high and 79% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at −9% fair-value upside, at −31%, NC6 screens richer than that median.

Fair Value

Bear A$0.0406 Fair Value A$0.0469 Bull A$0.0532
Price A$0.0680 · Downside -31.1%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 32/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 50
Are margins and returns getting better?
Cashflow 6
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 39
How calm the share price moves, does not count
Price momentum 47
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 69
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−4.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−62.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−51.9%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−345.8% (2020) → −13,679.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

NC6 screens overvalued: fair value 31% below the price. Compare with Tongkun Group →

Compare Nanollose Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 348 stocks

Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 32 · Bottom 25%
Fair Value upside −31.0% · Below median
Profitability
Return on assets −168.2% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 31.7% · Top 25%

Valuation Multiplesvs Textile Manufacturing median · lower = cheaper

P/B 22.74× · Priciest 25%
P/S (12 months) 87.61× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 11
FUTURE (revenue growth)100 · sector 37
PAST (return on equity)0 · sector 17
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)0 · sector 37

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Textile Manufacturing stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nanollose Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Nanollose Limited Fair Value". https://www.fairvalue-calculator.com/stock/NC6

Frequently asked questions

Is Nanollose Limited (NC6) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is A$0.0469 versus a price of A$0.0680, about 31% lower (overvalued).
What is the fair value of NC6?
Our estimate for Nanollose Limited is A$0.0469 (as of Nov 10, 2026), built from audited fundamentals. The current price: A$0.0680.
What is the quality score of NC6?
Nanollose Limited has a Quality Score of 32/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nanollose Limited (NC6)?
Our calculated price target is the estimate of A$0.0469 (as of Nov 10, 2026). Cautious scenario A$0.0406, optimistic scenario A$0.0532. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Nanollose Limited stock forecast for 2026?
Our estimate puts fair value at A$0.0469, about 31% lower versus a price of A$0.0680 (overvalued). Cautious scenario A$0.0406, optimistic scenario A$0.0532. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Nanollose Limited (NC6)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nanollose Limited it is A$0.0469 per share (as of Nov 10, 2026), against a price of A$0.0680.
Is Nanollose Limited stock overvalued or undervalued in 2026?
As of Nov 10, 2026, NC6 trades above its calculated fair value: price A$0.0680, fair value A$0.0469, a gap of about −31% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NC6?
No. The price is what the market pays today (A$0.0680); the fair value is what the company's own numbers justify (A$0.0469). For Nanollose Limited the two are A$0.0211 per share apart. That gap is exactly why we show both numbers side by side.
How much is Nanollose Limited worth?
The market values Nanollose Limited at about A$27.3M (market capitalisation, as of Nov 10, 2026). Per share that is A$0.0680; our models calculate a fair value of A$0.0469 per share.
What do the bullish and bearish scenarios say about NC6?
Our models span a range for Nanollose Limited: cautious scenario A$0.0406, base A$0.0469, optimistic A$0.0532 per share (as of Nov 10, 2026, price A$0.0680). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Nanollose Limited (NC6)?
Balance-sheet figures for Nanollose Limited (as of Nov 10, 2026): return on equity −300.3%. They feed the Quality Score of 32/100, which measures business quality independently of the share price.
How far is NC6 from its 52-week high?
Nanollose Limited trades at A$0.0680, about 18% below its 52-week high of A$0.0830 and 79% above the low of A$0.0380 (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0469 is for.
Which stocks are comparable to Nanollose Limited?
From the same area (Consumer Cyclical) we also value Tongkun Group, Shenzhou International Group, Inner Mongolia ERDOS Resources Co, Far Eastern New Century Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nanollose Limited stock attractive at the current price?
The data as of Nov 10, 2026: price A$0.0680, calculated fair value A$0.0469 (−31%), Quality Score 32/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Nanollose Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nanollose Limited (NC6)?
The closing price on Nov 10, 2026 was A$0.0680. Our estimate is A$0.0469, about 31% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nanollose Limited right now?
The price sits above even our optimistic bull case (A$0.0532). The favourable scenario is already priced in. Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Nanollose Limited

How large is the market capitalisation of Nanollose Limited (NC6)?
The market capitalisation of Nanollose Limited is A$27.3M (≈ $18.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nanollose Limited (NC6)?
The price-to-sales ratio of Nanollose Limited is 89.6 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nanollose Limited (NC6)?
Earnings per share at Nanollose Limited are A$−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Nanollose Limited (NC6)?
The return on equity (ROE) of Nanollose Limited is −300% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nanollose Limited (NC6)?
On an EBIT basis the return on assets of Nanollose Limited is −243% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nanollose Limited (NC6)?
The operating margin of Nanollose Limited is −277% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nanollose Limited (NC6)?
Revenue at Nanollose Limited is growing +31.7% versus a year earlier (3y avg −62.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Nanollose Limited (NC6) generate?
The free cash flow of Nanollose Limited is −A$1.8M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Nanollose Limited (NC6) hold?
Nanollose Limited holds more cash than debt, A$1.3M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Nanollose Limited in the live analysis

One click puts Nanollose Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.